|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C12N 15/09 | (2006.01) |
| A61K 38/00 | (2006.01) | ||
| A61K 45/00 | (2006.01) | ||
| A61P 37/00 | (2006.01) | ||
| A61P 37/06 | (2006.01) | ||
| C07K | (2006.01) | ||
| C07K 14/47 | (2006.01) | ||
| C07K 14/705 | (2006.01) | ||
| C07K 16/00 | (2006.01) | ||
| C07K 19/00 | (2006.01) | ||
| C12N 5/10 | (2006.01) | ||
| C12P 21/02 | (2006.01) | ||
| C12Q 1/02 | (2006.01) | ||
| G01N 33/68 | (2006.01) |
| (11) | Number of the document | 1248802 |
| (13) | Kind of document | T |
| (96) | European patent application number | 01937764.7 |
| Date of filing the European patent application | 2001-05-23 | |
| (97) | Date of publication of the European application | 2002-10-16 |
| (45) | Date of publication and mention of the grant of the patent | 2004-07-14 |
| (46) | Date of publication of the claims translation | 2004-10-25 |
| (86) | Number | PCT/US2001/017139 |
| Date | 2001-05-23 |
| (87) | Number | WO 2001/092337 |
| Date | 2001-12-06 |
| (30) | Number | Date | Country code |
| 579927 | 2000-05-26 | US | |
| 214065 P | 2000-06-26 | US |
| (72) |
PEACH, Robert, J., US
NAEMURA, Joseph, R., US
LINSLEY, Peter, S., US
BAJORATH, Jurgen, US
|
| (73) |
Bristol-Myers Squibb Company,
Lawrenceville-Princeton Road P.O. Box 4000, Princeton NJ 08543-4000,
US
|
| (74) |
Rita LAURINAVIČIŪTĖ,
Gedimino pr. 45-6, LT-01109 Vilnius,
LT
|
| (54) | Tirpios CTLA4 mutantinės molekulės ir jų panaudojimas |
| SOLUBLE CTLA4 MUTANT MOLECULES AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2020-04-23 | 347.00 EUR |